Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Epicon Biotech
Nanjing, Jiangsu, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Epicon Biotech operates a 16,000-square-foot GMP laboratory platform in Nanjing for processing, biobanking and preparation of clinical-grade cellular products (including CAR-T, CAR-NK and stem cell-derived exosomes/EVs) to support Avalon GloboCare’s and partners’ cellular therapy clinical programs.[9][11][13][14]
- Modalities
- CAR-T cell therapyNK cell therapyStem cell therapyExosome-based therapyLive biotherapeutic product therapy
- Industry
- Contract Manufacturing Organization
02
Partnerships
Avalon GloboCareJiangsu Unicorn Biological TechnologyGE Healthcare
Beyond the preview
Go deeper on Epicon Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Epicon Biotech.